By identifying and eliminating non-value-added activities, drug manufacturers can avoid falling into the same cost-traps in the future.
Jul 1, 2010
By:
James P. Catania
By identifying and eliminating non-value-added activities, drug manufacturers can avoid falling into the same cost-traps in the future.
|